"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer.

Eric Whitman is a General Surgeon and a Surgical Oncologist in Morristown, New Jersey. Dr. Whitman is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Melanoma, Pancreatic Cancer, Hyperparathyroidism, and Familial Pancreatic Cancer.

Lawrence Harrison, MD, is chief of Atlantic Surgical Oncology, which provides expert care across a broad spectrum of cancers, focusing on hepatobiliary, pancreatic, colorectal, gastroesophageal, skin and soft tissue cancers. As fellowship-trained surgical oncologists, Dr. Harrison and his partners provide patients with the latest in surgical innovations and clinical research options. Atlantic Surgical Oncology works closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and at Overlook Medical Center in Summit. Dr. Harrison has been a surgical innovator since finishing fellowship training at Memorial Sloan Kettering Cancer Center in New York City. He has extensive training in novel surgical techniques, including in hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery. Prior to joining Atlantic Surgical Oncology, Dr. Harrison served as director of surgical oncology at Valley Hospital in Ridgewood where he developed expertise in robotic surgery, performing more than 200 complex robotic surgical procedures. He also was director of the Advanced Gastrointestinal Surgical Fellowship. Previously, Dr. Harrison was associate professor of surgery and chief of the Division of Surgical Oncology at University Hospital in Newark for 12 years. In addition to his clinical practice, he was involved in research and taught medical residents and students. He is a fellow of the American College of Surgeons. Dr. Harrison sees patients at Morristown and Overlook medicals centers, and provides consultative services to Newton, Chilton and Hackettstown medical centers. Dr. Harrison is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Dr. Kai Bickenbach provides cancer patients with exceptional surgical care at Atlantic Surgical Oncology. His areas of specialty include melanoma, sarcoma, pancreatic cancer, liver and biliary cancer, esophageal and gastric cancer and colorectal cancer. He is trained in the use of many novel therapies, including the NanoKnife® to treat un-resectable pancreatic and liver tumors, as well as hepatic arterial infusion pumps. Dr. Bickenbach and his partners are fellowship trained surgical oncologists providing patients the latest in surgical innovation and clinical research options. Atlantic Surgical Oncology Associates work closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and Overlook Medical Center in Summit. Dr. Bickenbach is a member of a variety of medical organizations including the American College of Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology, and the Americas Hepato-Pancreatico-Biliary Association, and is a councilman for the New Jersey Chapter of the American College of Surgeons. He is widely published and has presented at national meetings on cancer related topics.After graduating from Wayne State University School of Medicine in 2002, Dr. Bickenbach completed his surgical residency at the University of Chicago Medical Center in 2009, where he was elected administrative chief resident. During that time, Dr. Bickenbach completed a two-year research fellowship, focusing on the use of oncolytic viruses in the treatment of cancer. Following residency, Dr. Bickenbach completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center. He sees patients at Morristown, Overlook, Newton, Chilton and Hackettstown medical centers. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Bickenbach is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Jaimin Shah is a Radiologist and an Interventional Radiologist in Morristown, New Jersey. Dr. Shah has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Ascites, Familial Pancreatic Cancer, Lung Cancer, Liver Embolization, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

David Gallinson is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gallinson is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Familial Colorectal Cancer, Anemia, Paget Disease of the Breast, Breast Cancer, and Bone Marrow Aspiration. Dr. Gallinson is currently accepting new patients.

Sarada Gurubhagavatula is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gurubhagavatula is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Gurubhagavatula is currently accepting new patients.

Larry Siu is a Gastroenterologist in Morristown, New Jersey. Dr. Siu is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Choledocholithiasis, Familial Pancreatic Cancer, Endoscopy, and Gastrectomy. Dr. Siu is currently accepting new patients.

Dr. Matthew Grossman is an interventional endoscopist and gastroenterologist with the Atlantic Digestive Health Institute at Morristown, specializing in premalignant conditions and malignancies involving the gastrointestinal (GI) system. Board-certified by the American Board of Internal Medicine in gastroenterology, and fellowship-trained in gastroenterology and advanced therapeutic endoscopy, Dr. Grossman cares for patients and is called upon for the most challenging endoscopic procedures.Dr. Grossman has performed thousands of advanced procedures providing the highest quality of care using state-of-the-art technology to diagnose and treat patients. His clinical interests are in therapeutic endoscopy: endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound, submucosal dissection and resection, and endoscopic surgical techniques including endoscopic bariatric surgery, esophageal and gastric POEM, Zenker’s diverticulectomy, transoral incisionless fundoplication, enteric stenting, double balloon enteroscopy, Barrett’s esophagus, pancreatic cyst management and endoscopic suturing.After earning his medical degree from Rutgers/UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ, Dr. Grossman completed his residency in internal medicine at Columbia University Medical Center, NYC. He then completed a fellowship in gastroenterology at New York University Medical Center, NYC, and went on for a second fellowship in advanced therapeutic endoscopy at Lenox Hill Hospital, NYC.Active in clinic trials of novel endoscopic devices as well as research on pancreatic cancer genomics, Dr. Grossman has written numerous publications in peer-reviewed journals and presented at many national scientific meetings. He has given frequent talks throughout the GI community about the latest innovations in endoscopy.Dr. Grossman is a Fellow of the New York Society for Gastrointestinal Endoscopy. He maintains active membership in the American Society for Gastrointestinal Endoscopy, the American College of Gastroenterology, and the American Gastroenterology Association. He is fluent in Spanish. Dr. Grossman is part of the Atlantic Medical Group and a participating provider of the Atlantic Accountable Care Organization. Dr. Grossman is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Achalasia, Angiodysplasia of the Colon, Bile Duct Obstruction, Endoscopy, and Pancreatectomy.

Lee Starker, MD, PhD, is a medical director of surgical oncology for the eastern region with a special interest in thyroid and parathyroid tumors and cancers, endocrine disorders, melanoma, hormones and metabolism, and cancer genetics. He is highly trained in pancreatic and complex hepatobiliary surgery. He also specializes in NanoKnife® to treat unresectable pancreatic and liver cancers as well as hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery for peritoneal malignancies.After completing his surgical residency at Yale New Haven Hospital in Connecticut and surgical oncology fellowship training at MD Anderson Cancer Center in Texas, Dr. Starker returned to his New Jersey roots. Prior to that, he earned a PhD in epigenetics and genetics of parathyroid tumors from Uppsala University in Sweden, where he was chief resident and fellow. While studying there, he received the Gold Humanism Award, which recognizes excellence in clinical care, leadership, compassion and dedication to service. He has also been named an NJ Top Doctor annually by NJ Monthly Magazine.Dr. Starker is widely published in various medical journals, including the World Journal of Oncology and International Journal of Endocrinology. He is a member of the Society of Surgical Oncology. Dr. Starker and his partners provide patients with the latest surgical innovations and clinical research options. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Starker is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.

Zubin Bamboat is a Surgical Oncologist and a General Surgeon in Florham Park, New Jersey. Dr. Bamboat is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy. Dr. Bamboat is currently accepting new patients.

Jessica Yang is a Hematologist and an Oncologist in Basking Ridge, New Jersey. Dr. Yang is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Stomach Cancer, Familial Pancreatic Cancer, and Pancreatic Cancer. Dr. Yang is currently accepting new patients.

Thaddeus Yablonsky is a Radiologist and an Interventional Radiologist in Morristown, New Jersey. Dr. Yablonsky is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Diverticular Disease, Bile Duct Obstruction, Chylous Ascites, Liver Embolization, and Gastrostomy. Dr. Yablonsky is currently accepting new patients.

Muhammad Abbasi is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Abbasi is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Abbasi is currently accepting new patients.

Benjamin Freeman is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Freeman is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Familial Colorectal Cancer, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Bone Marrow Aspiration. Dr. Freeman is currently accepting new patients.

Dr. Sonyo Shin is an esteemed attending hematologist/oncologist at Advanced Care Oncology and Hematology Associates (ACOHA), a distinguished part of Atlantic Medical Group (AMG). With over 20 years of dedicated experience in the field, she is deeply committed to delivering patient-centered care in both hematology and oncology.Dr. Shin is board-certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine. Her extensive expertise encompasses the treatment of a wide range of malignancies, including lymphoma, lung cancer, and chronic leukemia. She has been instrumental in developing and leading multidisciplinary breast cancer clinics, ensuring a comprehensive approach to patient care.In addition to her clinical practice, Dr. Shin is actively involved in clinical trials, contributing to the advancement of cancer research. She is also passionate about education, mentoring medical residents and students to foster the next generation of healthcare professionals. Her commitment to excellence in patient care and education underscores her role as a leader in the field of hematology and oncology. Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Dennis Han is a Gastroenterologist in Florham Park, New Jersey. Dr. Han is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Hereditary Pancreatitis, Acute Pancreatitis, Diverticular Disease, Gastrectomy, and Endoscopy. Dr. Han is currently accepting new patients.

William Diehl is a Surgical Oncologist and a General Surgeon in Florham Park, New Jersey. Dr. Diehl is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Intraductal Papilloma, Inflammatory Breast Cancer, and Lymphadenectomy. Dr. Diehl is currently accepting new patients.